MedTrace Logo

The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients

NCT05496179 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-04-12

No results posted yet for this study

Summary

to compare the effectiveness as well as the safety of prucalopride against metoclopramide as the first line treatment for feeding intolerance in critically ill patients.

Conditions

  • Enteral Feeding Intolerance

Interventions

DRUG

Prucalopride

Prokinetic

DRUG

Metoclopramide

Prokinetic

Sponsors & Collaborators

  • Future University in Egypt

    collaborator OTHER

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Eman Elmokadem, PhD · Future University in Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-30
Primary Completion
2023-06-10
Completion
2023-07-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05496179 on ClinicalTrials.gov